Apollo Biowellness, Inc., Merger Update
North Bergen, New Jersey--(Newsfile Corp. - October 9, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), is pleased to announce that it has completed the first step in the closing process with Revive Regenerative, Inc. The Company has secured the initial tranche of capital required in the amount of $500,000 as set forth in the merger agreement. In addition, the Company has finalized with GSS Capital to raise the additional $3,000,000 needed, with the terms agreed
Household / Consumer / Cosmetics, Health
2025-10-09 2:48 PM EDT | Apollo Biowellness, Inc.
Hemostemix Files for Ethics Approval of its Study of Vascular Dementia
Calgary, Alberta--(Newsfile Corp. - October 9, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it has filed its Institutional Review Board (IRB) application for approval of its Phase 1 clinical trial titled "Treatment of Vascular Cognitive Impairment and Dementia with Angiogenic Cell Precursors (ACP-01)." The 102-page submission marks a critical milestone in expanding the therapeutic reach of ACP
Biotechnology, Pharmaceuticals, Health
2025-10-09 9:03 AM EDT | Hemostemix Inc.
Psyched Wellness Provides Comprehensive Investor Update
Toronto, Ontario--(Newsfile Corp. - October 9, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to provide the following corporate update to its investors. Product Development & Launches Santa - Dietary Supplement Shot Following the initia
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2025-10-09 7:30 AM EDT | Psyched Wellness Ltd.
Neural Portfolio Company Hanf.com Reports Strong Fiscal 2024 Results with 65% Revenue Growth, Positive Cash Flow and Double-Digit Operating Margin; Continued Growth in 2025; First Half Revenues Up 31% Year-Over-Year
Toronto, Ontario--(Newsfile Corp. - October 8, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on therapeutic solutions for mental health conditions, together with its portfolio company CWE European Holdings Inc. ("CWE", operating as Hanf.com), one of Germany's leading hemp- and CBD-based retail platforms, is pleased to report the audited financial results of Hanf.com for the fis
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-10-08 9:37 AM EDT | Neural Therapeutics Inc.
Apollo Biowellness, Inc., Re-Engages GSS Capital
North Bergen, New Jersey--(Newsfile Corp. - October 8, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), is pleased to announce that it has re-engaged GSS Capital, a licensed Investment Bank and a member of FINRA, for advisory services to assist in the restructuring of the Company's Balance Sheet, coordinate the conversion of all convertible and secured debt of the Company to allow the Company to comply with the conditions of the Letter of Intent with Revive Regenerative,
Household / Consumer / Cosmetics, Health
2025-10-08 9:30 AM EDT | Apollo Biowellness, Inc.
Hazelden Betty Ford Recognized by Newsweek's "America's Best Addiction Treatment Centers 2025"
California and Newberg, Oregon--(Newsfile Corp. - October 8, 2025) - Hazelden Betty Ford has again been recognized by Newsweek's America's Best Addiction Treatment Centers in 2025, and is the largest, most frequently named national nonprofit provider on the 2025 listings. The annual rankings name the top treatment centers nationwide by state, based on quality of care, accreditation, reputation, and patient experience. The Hazelden Betty For
2025-10-08 9:00 AM EDT | Hazelden Betty Ford Foundation
Adia Nutrition Inc. Delivers Explosive Third Quarter Growth: Revenue Surges Over 100% from Prior Quarter, with Remarkable Profit Margin Exceeding 20%
Winter Park, Florida--(Newsfile Corp. - October 8, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a trailblazer in umbilical cord stem cells and exosome sales and therapies, today announced phenomenal preliminary financial results for the third quarter ended September 30, 2025. The company achieved a monumental revenue increase of more than 100% compared to the second quarter, while posting an extraordinary profit margin exceeding 20% for the quarter. This blockbuster performance cements Adia Nut
Healthcare and Hospitals, Health
2025-10-08 8:30 AM EDT | Adia Nutrition Inc.
Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms
Vancouver, British Columbia--(Newsfile Corp. - October 7, 2025) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("GENIX" or the "Company") wishes to clarify an error in its news release dated September 04, 2025, regarding the Company's recently closed non-brokered private placement. The previous release incorrectly stated that the Units were issued at a price of $0.10 per Unit.
Biotechnology, Pharmaceuticals, Health
2025-10-07 5:48 PM EDT | Genix Pharmaceuticals Corp.
Hemostemix's Insider Lead Order of $330,000 Private Placement
Calgary, Alberta--(Newsfile Corp. - October 7, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce a lead order of $330,000 for a non brokered private placement of up to $700,000. Purchasers may subscribe for Units at $0.11. Each Unit consists of one Common Share and one Warrant. Each Warrant may be exercised by the holder to acquire one Common Share at $0.15 for a period of two years from the Closing Date, subje
Biotechnology, Pharmaceuticals, Health
2025-10-07 10:05 AM EDT | Hemostemix Inc.
Hear At Last Launches Token on Solana Blockchain to Raise $10 Million for Portable Homes in Jamaica and North America
Miami, Florida--(Newsfile Corp. - October 7, 2025) - Hear At Last (OTCID: HRAL), a leader in innovative housing solutions, is proud to announce the creation of a new cryptocurrency token, HOHM, on the Solana blockchain. This initiative is aimed at raising $10 million to support the development and distribution of portable homes in Jamaica and North America. The HOHM token represents a groundbreaking step in combining blockchain technology with sustainable housing projects. By lev
Household / Consumer / Cosmetics, Health
2025-10-07 8:00 AM EDT | Hear AtLast Holdings, Inc
Edison Issues Report on Percheron Therapeutics (PER)
London, United Kingdom--(Newsfile Corp. - October 7, 2025) - Edison issues report on Percheron Therapeutics (ASX: PER) Percheron Therapeutics has reported final results from the Phase I dose escalation study of HMBD-002, its monoclonal antibody targeting VISTA, a novel immune checkpoint protein. The data confirmed the compound's favourable safety and tolerability profile (maximum tolerated dose not reached with <10% of patients experiencing grade 3 or greater adverse events), with e
Banking / Financial Services, Computer Hardware, Computer Software, Health
2025-10-07 4:38 AM EDT | Edison Group
Cosmo Pharmaceuticals Announces Regulatory Approval of Winlevi(R) in South Korea
Dublin, Ireland--(Newsfile Corp. - October 7, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced that the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea has approved Winlevi® (clascoterone) cream 1% for the treatment of acne vulgaris in patients aged twelve years and older. This approval marks another important milestone in Cosmo’s global dermatology expansion and r
Healthcare and Hospitals, Health
2025-10-07 1:09 AM EDT | Cosmo Pharmaceuticals N.V.
LevelJump Announces Reinstatement of Trading on the TSX Venture Exchange and Provides Corporate Updates
Toronto, Ontario--(Newsfile Corp. - October 6, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce that, further to its press release of June 24, 2025, trading on the TSX Venture Exchange (the "Exchange") will resume with trading expected to be reinstated on or about October 9, 2025. Disclosure relating to the Company's activities during the past 12 months (including an annual information form) is readily av
Healthcare and Hospitals, Health
2025-10-06 6:45 PM EDT | LevelJump Healthcare Corp.
Adia Nutrition Inc. Divests Biolete Coffee Subsidiary to Cement Factory LLC, Retains 18% Ownership to Support Strategic Focus on Regenerative Medicine and Medical Sales
Winter Park, Florida--(Newsfile Corp. - October 6, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine and innovative healthcare solutions, today announced the sale of its Biolete coffee subsidiary to Cement Factory LLC, a dynamic consumer products firm led by key owners Jeff Sciullo and AJ Sims. Adia will retain an 18% ownership stake in Cement Factory LLC, ensuring continued alignment with Biolete's growth while enabling Adia to concentrate resources on it
Healthcare and Hospitals, Health
2025-10-06 12:39 PM EDT | Adia Nutrition Inc.
Healing Realty Trust Acquires Highland Park Medical Office Building, a Fully Leased Healthcare Property in Highland Park, Illinois
Jupiter, Florida--(Newsfile Corp. - October 6, 2025) - Healing Realty Trust Inc. ("Healing Realty Trust," "HRT" or the "Company"), a healthcare-focused real estate investment company concentrated on acquiring value-add to core-plus medical office buildings with core-like, durable cash flows, is pleased to announce the acquisition of a single-story, multi-tenant medical office property located at 1160 Park Avenue West in Highland Park, Illinois. The asset was acquired for $4,915,000, represent
Banking / Financial Services, Real Estate, Health
2025-10-06 9:42 AM EDT | Healing Realty Trust
Delivra Health Brands Reports Continued Revenue Growth and Positive Adjusted EBITDA(1) in FY2025
Dream Water® USA and Dream Water® Canada achieve double digit revenue growth in e-commerce and retail channels LivRelief™ Canada achieves double-digit revenue growth in ecommerce Strong Dream Water and LivRelief results partially offset by reduced revenues in LivRelief Infused business. Management implementing new route-to-market strategy to recapture growth
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2025-10-06 7:30 AM EDT | Delivra Health Brands Inc.
Cannabis Bioscience International Holdings, Inc. Appoints Veteran Financier Andy Trivedi to Its Board of Directors, Strengthening Capital Strategy and Growth Outlook
Houston, Texas--(Newsfile Corp. - October 6, 2025) - Cannabis Bioscience International Holdings, Inc., (OTCID: CBIH), a publicly traded biomedical cannabis research and development company listed on the OTC Markets under the ticker symbol CBIH, today announced the appointment of Mr. Andy Trivedi, MBA, to its Board of Directors. The addition of Mr. Trivedi marks a strategic step forward in the Company's mission to scale operations, expand access to capital, and enhance long-term shareholder va
Biotechnology, Pharmaceuticals, Cannabis, Health
2025-10-06 7:00 AM EDT | Cannabis Bioscience International Holdings
Optimi Health's Psilocybin Capsules Selected for Medibank Insurance Program
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian GMP-compliant manufacturer of MDMA and psilocybin, today announced that its 5mg naturally-derived psilocybin capsules have been selected for inclusion in Medibank's psychotherapy program, an AUD $10 million insurance-backed initiative that has now been expanded to cover Treatment-Resistant Depression ("TRD
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-10-06 7:00 AM EDT | Optimi Health Corp.
Defence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025
Montreal, Quebec--(Newsfile Corp. - October 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce its participation at CPHI Worldwide 2025, taking place in Frankfurt, Germany from October 28-30, 2025. At this premier gathering and global trade fair of pharmaceutical leaders, Defence looks forward to engaging with potential partners acro
Biotechnology, Pharmaceuticals, Health
2025-10-06 3:15 AM EDT | Defence Therapeutics Inc.
MyndTec Inc. Completes Fifth Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - October 2, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed the fifth tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offering"). The fifth tranche of the private placement consists of 522,106 Units of the Company (the "Un
Technology, Healthcare and Hospitals, Health
2025-10-02 6:00 PM EDT | MyndTec Inc.